Evaluation of avelumab first-line (1L) maintenance therapy and subsequent treatment (tx) in patients (pts) with locally advanced or metastatic urothelial carcinoma (la/mUC) using a large claims database in Japan: JAVEMACS-D.
| Publicado en: | Journal of Clinical Oncology Vol. 43; pp. 700 - 942 |
|---|---|
| Autores principales: | , , , , , , |
| Formato: | Journal Article |
| Publicado: |
American Society of Clinical Oncology
2/10/2025 Supplement5
|
| Acceso en línea: | Ver este registro en EBSCOhost |
| Descripción no disponible. |